Serum Irisin Level Among Patients with Subclinical Hypothyroidism in Relation with Plasma Atherogenic Indices

Asin Irfan  Saeed; Dhia Mustafa  Sulaiman; Sherwan Farman  Salih

doi:10.56056/

Authors

Asin Irfan Saeed Iraqi Board of Medical Specializations (IBMS) /Chemical Pathology. MBCHB, Rizgary teaching hospital, MOH-DOH Erbil
Dhia Mustafa Sulaiman Assistant Professor in Clinical Biochemistry a d Metabolic Medicine, MBChB, Msc,Ph.D. Duhok Polytechnic University
Sherwan Farman Salih Assistant Professor in Chemical Pathology, MBChB- FIBMS (Chemical Pathology). Fellowship of the Iraqi Board for Medical specializations (FIBMS). University of Duhok-college of Medicine

DOI:

https://doi.org/10.56056/

Keywords:

Atherogenic indices, Irisin, Overweight/obesity, Subclinical hypothyroidism

Abstract

Background and objectives: Subclinical hypothyroidism, impacting 3-8% of the general population with a higher incidence in women and older individuals, is linked to cardiovascular and atherosclerosis. This study evaluated the serum irisin levels in individuals with newly diagnosed subclinical hypothyroidism compared to a control group, explored its association with atherogenic plasma indices.

Methods: A case-control study, enrolled 160 participants, including 80 with newly diagnosed subclinical hypothyroidism and 80 euthyroid individuals as controls. The study was conducted at the Endocrine Department of Rzgary Teaching Hospital in Erbil City, Iraq. The study was conducted between September 2022 - September 2023. Blood samples were collected for measurement of serum irisin levels, thyroid hormones, lipid profile, anti- thyroid peroxidase antibodies, and atherogenic indices.

Results: Notably, 76.3% of Subclinical Hypothyroidism cases were young females (<40, p<0.001) with higher rates of overweight/obesity (73.8%) compared to controls (p<0.001). Waist circumference and thyroid hormone levels were significantly higher in subclinical hypothyroidism cases (p<0.001). The prevalence of high atherogenic coefficient was higher in cases (83.7% vs. 63.8%, p=0.004). Thyroid stimulating hormone levels were elevated in subclinical hypothyroidism cases (7.37?-IU/mL) compared to controls (2.67?-IU/mL) (p < 0.001). Anti- thyroid peroxidase antibodies titer was significantly higher in cases (54.37 IU/mL) than controls (16.55 IU/mL) (p < 0.001).

Conclusions: Subclinical hypothyroidism is prevalent among young obese females. Serum irisin levels remain steady in subclinical hypothyroidism compared to healthy controls but positively correlate with atherogenic indices in these patients.

Downloads

Download data is not yet available.

References

1. Afroz A, Ali L, Karim M, Alramadan MJ, Alam K, Magliano DJ. et al. Glycaemic control for people with type 2 diabetes mellitus in Bangladesh-an urgent need for optimization of management plan. Sci Rep. 2019;9(1):1-10.

2. Akour A, Kasabri V, Boulatova N, Bustanji Y, Naffa R, Hyasat D, et al. Levels of metabolic markers in drug-naive prediabetic & type 2 diabetic patients. Acta Diabetol. 2017;54(2):163-170.

3. American Diabetes Association (ADA). Management of dyslipidemia in adults with diabetes. Diabetes Care. 2003;26(suppl_1): S83-S86.

4. American Diabetes Association (ADA). Classification & Diagnosis of Diabetes: Standards of medical care in Diabetes-2021. Diabetes Care. 2021 Jan;44(Suppl 1): S15-S33.

5. Aroda VR, Ratner R. Approach to the patient with prediabetes. J Clin Endocrinol Metab. 2008;93(9):3259-3265.

6. Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ. Physical activity & the risk of type 2 diabetes: a systematic review & dose–response meta-analysis. Eur J Epidemiol. 2015;30(7):529-542.

7. Bhowmik B, Siddiquee T, Mujumder A, Afsana F, Ahmed T, Mdala IA, et al. Serum lipid profile & its association with diabetes & prediabetes in a rural Bangladeshi population. Int J Environ Res Public Health. 2018;15(9):1944.

8. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1 -?-dependent myokine that drives brown-fat-like development of white fat & thermogenesis. Nature. 2012;481(7382):463-468.

9. Casadei K, Kiel J. Anthropometric Measurement In: StatPearls. Treasure Island (FL): StatPearls Publishing; 30726000. https://pubmed.ncbi.nlm.nih.gov/30726000/

10. de la Iglesia R, Lopez?Legarrea P, Crujeiras AB, Pardo M, Casanueva FF, Zulet MA, et al. Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients. Clin Endocrinol. 2014;81(2):306-311.

11. Duran ID, Gülçelik NE, Ünal M, Topçuo?lu C, Sezer S, Tuna MM, et al. Irisin levels in the progression of diabetes in sedentary women. Clin Biochem. 2015;48(18):1268-1272.

12. Ebert T, Kralisch S, Wurst U, Scholz M, Stumvoll M, Kovacs P, et al. Association of metabolic parameters & rs726344 in FNDC5 with serum irisin concentrations. Int J Obes. 2016;40(2):260-265.

13. Goldberg IJ. Diabetic dyslipidemia: causes & consequences. J Clin Endocrinol Metab. 2001;86(3):965-971.

14. Ibrahim I, Salih S. Serum Irisin in Individuals with Type 2 Diabetes Mellitus & Prediabetes in Duhok City. J Life & Bio-sci Res. 2022;03(02):59–64.

15. Weir CB, Jan A. BMI Classification Percentile and Cut Off Points. 2023. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31082114. https://pubmed.ncbi.nlm.nih.gov/31082114/

16. Shimizu Y, Kawashiri SY, Noguchi Y, Nagata Y, Maeda T, Hayashida N, et al. Anti-thyroid peroxidase antibody and subclinical hypothyroidism in relation to hypertension and thyroid cysts. PLOS ONE. 2020; 15(10): e0240198. https://doi.org/10.1371/journal.pone.0240198/

17. Shimizu Y, Kawashiri SY, Noguchi Y, Nagata Y, Maeda T, Hayashida N. Normal range of anti-thyroid peroxidase antibody (TPO-Ab) and atherosclerosis among eu-thyroid population: A cross-sectional study. Medicine. 2020;99(38): e22214. doi:10.1097/MD.0000000000022214/

18. Karthick N, K.Dillara , Poornima K, Subhasini A. Dyslipidaemic Changes in Women with Subclinical Hypothyroidism. J Clin of Diagn Res.2013; 7(10):2122-2125.

19. Haghi AR, Solhjoo M, Tavakoli MH. Correlation Between Subclinical Hypothyroidism & Dyslipidemia. Iran J Pathol. 2017;12: 106-111.

20. Mahdavi-Roshan M, Shoaibinobarian N, Noormohammadi M, Mousavi AF, Rakhsh AS, Salari A, et al. Inflammatory Markers and Atherogenic Coefficient: Early Markers of Metabolic Syndrome. Int J Endocrinol Metab. 2022;20(4): e127445. doi:10.5812/ijem-127445/

21. Salcedo-Cifuentes M, Belalcazar S, Acosta EY, Medina-Murillo JJ. Conventional biomarkers for cardiovascular risks & their correlation with the castelli risk index-indices & tg/hdl-c. Arch Med (Manizales). 2019; 20:11–22.

22. Dobiášová M, Frohlich J, Šedová M, Cheung MC, Brown BG. Cholesterol esterification & atherogenic index of plasma correlate with lipoprotein size & findings on coronary angiography. J Lipid Res. 2011; 52:566.

23. Nwagha U, Ikekpeazu EJ, Ejezie FE, Neboh EE, Maduka IC. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. Afr Health Sci. 2010; 10:248.

24. Salih SF. The prevalence of thyroid dysfunction among women with type 2 diabetes mellitus in Duhok. Duhok Med J. 2015;9(2):52-59.

25. Cojic M, Cvejanov-Kezunovic L. Subclinical Hypothyroidism – Whether & When to Start Treatment? Open Access Maced J Med Sci. 2017; 5:1042.

26. Blum MR, Gencer B, Adam L, Feller M, Collet TH, da Costa BR, et al. Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly with Subclinical Hypothyroidism: A Randomized Trial. J Clin Endocrinol Metab. 2018;103(8):2988-2997. doi: 10.1210/jc.2018-00279. PMID: 29846630.

27. Goswami T, Goswami K. Castelli risk index-1 & atherogenic coefficient are better predictors of cardiometabolic risk in patients with hypothyroidism. Int J Clin Biochem Res. 2020; 7:254–259.

28. Dobiášová M. Atherogenic Index of Plasma [Log (Triglycerides/HDL-Cholesterol)]: Theoretical & Practical Implications. Clin Chem. 2004; 50:1113–1115.

29. Qasim B, Arif S, Muhammed A, Abduljabbar R. Dyslipidemia in Subclinical Hypothyroidism: A Case-Control Study. J Endocrinol Diabetes. 2018; 5:1–6.

30. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels & predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf). 2004; 61:232–238.

31. Zhu X, Cheng S. New insights into regulation of lipid metabolism by thyroid hormone. Curr Opin Endocrinol Diabetes Obes. 2010; 17:408–413.

32. Axelb F, Dias J, Ferrão FM, Einicker-Lamas M. Nongenomic signaling pathways triggered by thyroid hormones & their metabolite 3-iodothyronamine on the cardiovascular system. J Cell Physiol. 2011; 226:21–28.

33. Rizos CV, Elisaf MS, Liberopoulos EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 2011; 5:76-84. doi:10.2174/1874192401105010076

34. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-?-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463-8. doi: 10.1038/nature10777. PMID: 22237023; PMCID: PMC3522098.

35. Broeders E, Bouvy ND, Van Marken Lichtenbelt WD. Endogenous ways to stimulate brown adipose tissue in humans. Ann Med. 2015; 47:123–132.

36. de Oliveira M, Mathias LS, Rodrigues BM, Mariani BG, Graceli JB, De Sibio MT, et al. The roles of triiodothyronine and irisin in improving the lipid profile and directing the browning of human adipose subcutaneous cells. Mol Cell Endocrinol. 2020; 506:110744. doi: 10.1016/j.mce.2020.110744. Epub 2020 Feb 3. PMID: 32027943.

37. Panagiotou G, Pazaitou-Panayiotou K, Paschou SA, Komninou D, Kalogeris N, Vryonidou A, et al. Changes in Thyroid Hormone Levels Within the Normal and/or Subclinical Hyper- or Hypothyroid Range Do Not Affect Circulating Irisin Levels in Humans. Thyroid. 2016;26(8):1039-45. doi: 10.1089/thy.2016.0098. PMID: 27267080.

38. Chen Z, Zhang Q, Peng N, Hu Y, Li H, He X, et al. Association of serum irisin concentration with thyroid autoantibody positivity and subclinical hypothyroidism. J Int Med Res. 2021;49(5):3000605211018422. doi:10.1177/03000605211018422/

39. Stratigou T, Dalamaga M, Antonakos G, Marinou I, Vogiatzakis E, Christodoulatos GS, et al. Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factors. Endocrine. 2018;61(1):83-93. doi: 10.1007/s12020-018-1550-3. Epub 2018 Feb 17. PMID: 29455364.